e-learning
resources
Milan 2017
Sunday, 10.09.2017
Towards personalised medicine in COPD: biological and clinical phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
S. Everaerts (LEUVEN, Belgium)
Source:
International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Session:
Towards personalised medicine in COPD: biological and clinical phenotypes
Session type:
Oral Presentation
Number:
509
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Everaerts (LEUVEN, Belgium). Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD. 509
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The contribution of
Aspergillus fumigatus
to COPD exacerbations: a “sensitive” topic
Source: Eur Respir J, 56 (2) 2002223; 10.1183/13993003.02223-2020
Year: 2020
Aspergillus fumigatus during stable state and exacerbations of COPD
Source: Eur Respir J 2014; 43: 64-71
Year: 2004
Transmission-frequency of Aspergillus fumigatus in cystic fibrosis patients through coughing
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Aspergillus fumigatus sensitization in COPD and smokers
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Interleukin-10 genotypes and airways colonization by
Aspergillus fumigatus
in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005
Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Allergic bronchopulmonary aspergillosis (ABPA) by
Aspergillus flavus
Source: Eur Respir J 2001; 18: Suppl. 33, 218s
Year: 2001
Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011
Tracheal oxalosis associated with Aspergillus niger tracheobronchitis
Source: Eur Respir J 2013; 41: 995-997
Year: 2013
Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Performance of Siemens immulite immunoassay for detection of Aspergillus fumigatus and Aspergillus flavus specific IgG for chronic pulmonary aspergillosis diagnosis in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Clinical application and radiological relavance for Aspergillus fumigatus- and flavus-specific IgG in chronic Pulmonary Aspergillus infection>
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Aspergillus sensitization and aspergillus-associated diseases in a sample of patients with severe asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis
Source: Eur Respir J 2006; 28: 352-357
Year: 2006
IgE sensitization to Aspergillus fumigatus among children in allergological centre of Saratov
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
What is the significance of aspergillus fumigatus in BAL in children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept